These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12891291)

  • 1. [Angiotensin1-receptor antagonist losartan. Part I. Basic clinical pharmacology].
    Sidorenko BA; Preobrazhenskiĭ DV; Stetsenko TM; Malysheva NV; Tsurko VV; Tarykina EV
    Kardiologiia; 2003; 43(1):90-8. PubMed ID: 12891291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blocker of angiotensin-1 receptor antagonist losartan. Part III. Experience in therapy for chronic heart failure and after acute myocardial infarction].
    Sidorenko BA; Preobrazhenskiĭ DV; Stetsenko TM; Tarykina EV; Tsurko VV
    Kardiologiia; 2003; 43(3):93-8. PubMed ID: 12891263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiotensin I receptor antagonist losartan. Part II. Effects in arterial hypertension and diabetic nephropathy].
    Sidorenko BA; Preobrazhenskiĭ DV; Stetsenko TM; Tarykina EV; Tsurko VV
    Kardiologiia; 2003; 43(2):88-95. PubMed ID: 12891278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan: a review of its use, with special focus on elderly patients.
    Simpson KL; McClellan KJ
    Drugs Aging; 2000 Mar; 16(3):227-50. PubMed ID: 10803861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension.
    McIntyre M; Caffe SE; Michalak RA; Reid JL
    Pharmacol Ther; 1997; 74(2):181-94. PubMed ID: 9336021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiarrhythmic potential of angiotensin II antagonism: experience with losartan.
    Gavras I; Gavras H
    Am J Hypertens; 2000 May; 13(5 Pt 1):512-7. PubMed ID: 10826402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin blockade for hypertension: a promise fulfilled.
    Brunner HR; Gavras H
    Lancet; 2002 Mar; 359(9311):990-2. PubMed ID: 11937175
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin receptor antagonists.
    Wong W; Howes L
    Aust Fam Physician; 2000 Jul; 29(7):653-5, 658. PubMed ID: 10914449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Losartan in therapy of chronic heart failure].
    Vizir VA; Berezin AE
    Klin Med (Mosk); 2000; 78(2):36-9. PubMed ID: 10723150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
    Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
    Coca A; Giner V
    Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin receptor antagonist for therapy of patients with hypertension].
    Rakugi H; Ogihara T
    Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LIFE: losartan versus atenolol.
    Chong AY; Lip GY
    Lancet; 2003 Oct; 362(9393):1416. PubMed ID: 14585648
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of the angiotensin receptor antagonist losartan on the response of the left main coronary artery to cold pressor test in patients with essential hypertension as assessed by echocardiography.
    Deng YB; Wang DW; Li CL; Yang HY
    Can J Cardiol; 2002 Apr; 18(4):389-96. PubMed ID: 11992132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of losartan and captopril in ELITE II.
    Hall A
    Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022946
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of losartan and captopril in ELITE II.
    Meyer FP
    Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022947
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
    Ozer MK; Sahna E; Birincioglu M; Acet A
    Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.